Onconova Therapeutics, Inc.
USD35.91
+5.66 (+18.73%)
CEO
Steven M. Fruchtman
IPO Date
2013-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.58
Prev. Close
$30.24
Day Low
$31.58
Day High
$43.14
52W Low
$24.00
52W High
$43.14
Market Cap
$0.75B
Volume
0.10M
| 8,727 |
| $0.90 |
| 15 Mar 2024 | Fruchtman Steven M | director, officer: PRESIDENT, CHIEF EXECUTIVE OFF | M-Exempt | Disposed | 23,111 | $0.00 |
| 15 Mar 2024 | Guerin Mark Patrick | CFO AND COO | M-Exempt | Acquired | 8,666 | $0.00 |
| 15 Mar 2024 | Guerin Mark Patrick | CFO AND COO | F-InKind | Disposed | 2,591 | $0.90 |
| 15 Mar 2024 | Guerin Mark Patrick | CFO AND COO | M-Exempt | Disposed | 8,666 | $0.00 |
| 9 Feb 2024 | Fruchtman Steven M | director, officer: PRESIDENT, CHIEF EXECUTIVE OFF | M-Exempt | Acquired | 21,320 | $0.00 |
| 9 Feb 2024 | Fruchtman Steven M | director, officer: PRESIDENT, CHIEF EXECUTIVE OFF | F-InKind | Disposed | 9,212 | $0.67 |
| 9 Feb 2024 | Fruchtman Steven M | director, officer: PRESIDENT, CHIEF EXECUTIVE OFF | M-Exempt | Disposed | 21,320 | $0.00 |
| 9 Feb 2024 | Guerin Mark Patrick | CFO AND COO | M-Exempt | Acquired | 6,900 | $0.00 |